Cas:75443-99-1 Aclarubicin hydrochloride manufacturer & supplier

Chemical Name:Aclarubicin hydrochloride

CAS.NO:75443-99-1

Synonyms:Aclarubicin HCl;Aclacin;1-Naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyra nosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-, methyl ester, (1R,2R,4S)-, hydrochloride (1:1);Aclacinomycin A hydrochloride;Aclarubicin hydrochloride;methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl}-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate hydrochloride (1:1);1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy]-, methyl ester, (1R,2R,4S)-, hydrochloride (1:1);Methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl}-3-(dimethylamino)-α-L-lyx o-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydro-1-tetracenecarboxylate hydrochloride (1:1)

Molecular Formula:C₄₂H₅₄ClNO₁₅

Molecular Weight:848.329

HS Code:

Physical and Chemical Properties:

Melting point:151-153℃

Boiling point:897.7ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:217.05000

Exact Mass:847.318176

LogP:3.95970

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3249

Packing Group:II

Contact us for information like Aclarubicin HCl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl}-3-(dimethylamino)-α-L-lyx o-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydro-1-tetracenecarboxylate hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Aclarubicin hydrochloride Use and application,Methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl}-3-(dimethylamino)-α-L-lyx o-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydro-1-tetracenecarboxylate hydrochloride (1:1) technical grade,usp/ep/jp grade.

Related News: RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO methyl (E)-4-(3-(isoindolin-2-yl)prop-1-en-1-yl)benzoate manufacturers On top of getting compensated for the past infringements, Plexxikon says it will receive “additional royalty payments for future sales of Tafinlar in the United States through the life of the patents.” 3-(1-{2-[5-(Isobutanoylamino)-2-methylphenyl]ethyl}piperidin-4-yl)-6-chloro-1H-indole suppliers Earlier this month, the drugmaker lifted a voluntary EU marketing hold on Zynteglo for beta thalassemia, after a patient death in one of the drugmaker’s other products, LentiGlobin, halted clinical studies. L-Arginine, N2-[1-[N2-[N-(1-oxooctadecyl)-L-threonyl]-L-lysyl]-L-prolyl]- vendor & factory.